Hangzhou Diagens Biotechnology's (HKG:2526) AI AutoVision core product obtained a Class III Medical Device Registration Certificate from China's National Medical Products Administration.

The approved indications under the certificate cover chromosome karyotype analysis for prenatal diagnosis of birth defects using amniotic fluid samples and assisted reproduction using peripheral blood samples, according to a Friday filing with the Hong Kong bourse.